Mintz represented Granata Bio Corporation (Granata Bio), a biopharma company focused on invigorating the $3.6B global infertility medication market, in its $15M Series A+ funding round. 

The funding round will support Granata Bio's efforts to explore new innovative assets in reproductive health and further strengthen its position as a leader within the reproductive health space. More information is available here.

The Mintz team was led by Member Tom Burton and Associate Sarah Palmer, with support from Associates Lorena Niebla, Elana Lerner-Brockmann, and Becca Horton.

About Mintz

Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto.